SenoRx, Inc. Lowers IPO Price Range to $9-$10 per Share
WASHINGTON, March 28 (Reuters) - Medical device maker SenoRx Inc. on Wednesday lowered its planned initial public offering to between $9 and $10 per share from a previous estimate of $11 to $13 each.